Across TCGA pan-cancer cohorts, RRP7A Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RRP7A data layer compared with 29 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RRP7A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RRP7A expression acts as an unfavorable survival marker.

COAD and STAD are the cancer types where RRP7A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.133	0.875	<.001	24	view →
STAD	OS	Median	II,III,IV	0.183	0.676	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RRP7A tumor-vs-normal RNA expression · all RRP7A data types